U.S. Supreme Court Decides Fate of Three Key § 101 Cases


Today the U.S. Supreme Court decided the fate of three patent cases whose resolution depended largely on the Court’s holding in Bilski v. Kappos. The Supreme Court’s decision on whether it would hear argument in Classen Immunotherapies, Inc. v. Biogen IDEC, Mayo Collaborative Svcs. v. Prometheus Labs., and Ferguson v. U.S. Patent & Trademark Office, had been pending since before the Court heard argument in Bilski on November 9, 2009.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Health Updates, Intellectual Property Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Finnegan | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »